Literature DB >> 2313777

Viral aetiology of acute respiratory infections in children in north India.

P K Misra1, R S Chaudhary, A Jain, A Pande, A Mathur, U C Chaturvedi.   

Abstract

Two hundred and thirty children clinically diagnosed as suffering from acute respiratory infection were tested for four major groups of viral aetiological agents, i.e. influenza para-influenza, respiratory syncytial virus (RSV) and adenoviruses using indirect immunofluorescence technique. At least one of the respiratory viruses was identified in 51 (22 per cent) specimens, which included influenza A in 6 (3 per cent), influenza B in 3 (1 per cent), para-influenza type 1 in 3 (1 per cent), para-influenza type 3 in 13 (6 per cent), RSV in 11 (5 per cent) adenovirus in 12 (5 per cent), and dual virus infections in 3 (1 per cent) cases. Maximum number of virus identification was noted in children below 1 year of age, particularly infection with RSV followed by para-influenza and adenoviruses. Value of rapid diagnosis by indirect immunofluorescence technique is stressed.

Entities:  

Mesh:

Year:  1990        PMID: 2313777     DOI: 10.1093/tropej/36.1.24

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  3 in total

Review 1.  Respiratory syncytial virus infection: clinical presentation and management.

Authors:  J A Patel; K Deka; P L Ogra
Journal:  Indian J Pediatr       Date:  1995 Jan-Feb       Impact factor: 1.967

2.  Genetic variability in the G protein gene of group A and B respiratory syncytial viruses from India.

Authors:  Shama Parveen; Wayne M Sullender; Karen Fowler; Elliot J Lefkowitz; Suresh Kumar Kapoor; Shobha Broor
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

3.  Clinical and epidemiological characteristics of influenza virus infection in hospitalized children with acute respiratory infections in Sri Lanka.

Authors:  Rukshan A M Rafeek; Maduja V M Divarathna; Adrian J Morel; Faseeha Noordeen
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.